Encephalopathy screening: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
==Screening==
==Screening==
==='''Subclinical Hepatic Encephalopathy'''===
==='''Subclinical Hepatic Encephalopathy'''===
A study involved detecting encephalopathy in patients of cirrhosis. Psychometric assessment, automated analysis of EEG and sickness impact profile are used to diagnose the encephalopathy. Combined evaluation of results of these tests helps in detecting subclinical encephalopathy.<ref name="pmid10845661">{{cite journal |author=Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW |title=Screening of subclinical hepatic encephalopathy |journal=J. Hepatol. |volume=32 |issue=5 |pages=748–53 |year=2000 |month=May |pmid=10845661 |doi= |url=}}</ref>
Psychometric assessment, automated analysis of EEG and sickness impact profile can be used to diagnose subclinical encephalopathy. Combined evaluation of results of these tests helps in detecting subclinical encephalopathy.<ref name="pmid10845661">{{cite journal |author=Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW |title=Screening of subclinical hepatic encephalopathy |journal=J. Hepatol. |volume=32 |issue=5 |pages=748–53 |year=2000 |month=May |pmid=10845661 |doi= |url=}}</ref>


==='''Bilirubin Encephalopathy'''===
==='''Bilirubin Encephalopathy'''===

Revision as of 11:58, 24 July 2012

Encephalopathy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Encephalopathy from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Electroencephalogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Encephalopathy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Encephalopathy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Encephalopathy screening

CDC on Encephalopathy screening

Encephalopathy screening in the news

Blogs on Encephalopathy screening

Directions to Hospitals Treating Encephalopathy

Risk calculators and risk factors for Encephalopathy screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Screening helps in identification of impending encephalopathy or detection of subclinical encephalopathy. Presently strategies for detecting subclinical hepatic encephalopathy[1] and neonatal encephalopathy[2] due to raised bilurubin levels exist.

Screening

Subclinical Hepatic Encephalopathy

Psychometric assessment, automated analysis of EEG and sickness impact profile can be used to diagnose subclinical encephalopathy. Combined evaluation of results of these tests helps in detecting subclinical encephalopathy.[1]

Bilirubin Encephalopathy

A single test or study is not effective in detecting the bilirubin encephalopathy. Based on retrospective analyses among infants who had both early and late TSB measurements available, the combination of risk factors and early TSB measurement has better diagnostic ability to predict clinically significant hyperbilirubinemia compared to risk factors alone.[3]

References

  1. 1.0 1.1 Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW (2000). "Screening of subclinical hepatic encephalopathy". J. Hepatol. 32 (5): 748–53. PMID 10845661. Unknown parameter |month= ignored (help)
  2. http://www.ncbi.nlm.nih.gov/books/NBK34036/
  3. http://www.ncbi.nlm.nih.gov/books/NBK34036/

Template:WH Template:WS